Ligand validation:4KLY

RET: RETINAL

RET is a Ligand Of Interest in 4KLY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4KLY_RET_B_301	74%	7%	0.12	0.95	1.08	3.67	1	12	4	0	100%	0.9524
4KLY_RET_E_301	71%	8%	0.119	0.939	0.84	3.67	-	16	2	0	100%	0.9524
4KLY_RET_C_301	69%	7%	0.128	0.943	1.4	3.3	1	11	6	0	100%	0.9524
4KLY_RET_A_301	63%	6%	0.132	0.926	0.96	4.09	-	14	2	0	100%	0.9524
4KLY_RET_D_301	57%	9%	0.165	0.94	0.87	3.5	-	14	1	0	100%	0.9524
4KNF_RET_C_301	41%	8%	0.236	0.954	0.93	3.63	1	16	4	0	100%	0.9524
4OV0_RET_A_301	100%	8%	0.027	0.992	0.76	3.77	-	15	4	0	100%	0.9524
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	0.9524
3UTX_RET_B_301	100%	6%	0.042	0.988	2.42	2.7	5	12	4	0	100%	0.9524
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
5G28_RET_A_1268	97%	23%	0.051	0.968	1.29	1.84	3	5	0	0	100%	0.9524

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.